New Pill in Development to Protect Humans from Lyme Disease

  • 📰 WIRED
  • ⏱ Reading Time:
  • 6 sec. here
  • 8 min. at publisher
  • 📊 Quality Score:
  • News: 27%
  • Publisher: 51%

Health News

Tarsus Pharmaceuticals,Pill,Lyme Disease

Tarsus Pharmaceuticals is developing a pill for humans that can provide protection against Lyme disease for several weeks. Results from a small trial showed that the drug can kill ticks on people within 24 hours of taking it, with effects lasting up to 30 days. The company aims to create a preventive measure that can protect individuals before they are bitten by ticks.

Tarsus Pharmaceuticals is developing a pill for humans that can provide protection against Lyme disease for several weeks. Results from a small trial showed that the drug can kill ticks on people within 24 hours of taking it, with effects lasting up to 30 days.

The company aims to create a preventive measure that can protect individuals before they are bitten by ticks.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 555. in LAW

Law Law Latest News, Law Law Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

A Pill That Kills Ticks Is a Promising New Weapon Against Lyme DiseaseYour pets can already eat a chewable tablet for tick prevention. Now, a pill that paralyzes and kills ticks has shown positive results in a small human trial.
Source: WIRED - 🏆 555. / 51 Read more »

Novo Nordisk’s New Obesity Pill Beats Wegovy In Early TrialI am a senior reporter for the Forbes breaking news team, covering health and science from the London office. Previously I worked as a reporter for a trade publication covering big data and law and as a freelance journalist and policy analyst covering science, tech and health.
Source: Forbes - 🏆 394. / 53 Read more »

Novo Nordisk market cap surpasses Tesla on new obesity pill trial dataWegovy obesity drug maker Novo Nordisk surpassed Tesla in market value Thursday after fresh early trial data showed positive results for its new experimental weight loss pill.
Source: CNBC - 🏆 12. / 72 Read more »